Complement-binding anti-HLA antibodies and kidney-allograft survival.
about
Donor-Specific Anti-HLA Antibodies in Allogeneic Hematopoietic Stem Cell TransplantationLiver transplantation: Current status and challengesThe Influence of Immunosuppressive Agents on the Risk of De Novo Donor-Specific HLA Antibody Production in Solid Organ Transplant RecipientsNew directions for rabbit antithymocyte globulin (Thymoglobulin(®)) in solid organ transplants, stem cell transplants and autoimmunityFactors influencing long-term outcome after kidney transplantationMemory B cells in transplantationComplement cascade and kidney transplantation: The rediscovery of an ancient enemyThe perfect storm: HLA antibodies, complement, FcγRs, and endothelium in transplant rejectionEffects of complement activation on allograft injuryHLA antibody detection with solid phase assays: great expectations or expectations too great?Vascular endothelium as a target of immune response in renal transplant rejectionUnraveling the Role of Allo-Antibodies and Transplant InjuryFcγ Receptors in Solid Organ TransplantationAntibody Subclass Repertoire and Graft Outcome Following Solid Organ TransplantationThe Biological Effects of IL-21 Signaling on B-Cell-Mediated Responses in Organ TransplantationImmune-mediated vascular injury and dysfunction in transplant arteriosclerosisThe Complement System and Antibody-Mediated Transplant RejectionApplication of High-Throughput Next-Generation Sequencing for HLA Typing on Buccal Extracted DNA: Results from over 10,000 Donor Recruitment SamplesThe Spectrum of Renal Allograft FailureThe Humoral Theory of Transplantation: Epitope Analysis and the Pathogenicity of HLA Antibodies.Desensitization: Overcoming the Immunologic Barriers to TransplantationBlockade of HLA Antibody-Triggered Classical Complement Activation in Sera from Subjects Dosed with the Anti-C1s Monoclonal Antibody TNT009 - Results from a Randomized First-in-Human Phase 1 Trial.Molecules Great and Small: The Complement System.Allogeneic major histocompatibility complex-mismatched equine bone marrow-derived mesenchymal stem cells are targeted for death by cytotoxic anti-major histocompatibility complex antibodiesTechnical Limitations of the C1q Single-Antigen Bead Assay to Detect Complement Binding HLA-Specific Antibodies.Immunologic human renal allograft injury associates with an altered IL-10/TNF-α expression ratio in regulatory B cells.Activation of complement factor B contributes to murine and human myocardial ischemia/reperfusion injury.The UK National Registry of ABO and HLA Antibody Incompatible Renal Transplantation: Pretransplant Factors Associated With Outcome in 879 TransplantsTransplantation: Complementing donor-specific antibody testing.Current status of alloimmunity.The kSORT assay to detect renal transplant patients at high risk for acute rejection: results of the multicenter AART study.Quantifying renal allograft loss following early antibody-mediated rejection.Detection of C3d-binding donor-specific anti-HLA antibodies at diagnosis of humoral rejection predicts renal graft loss.Global scientific vision with local vigilance: renal transplantation in developing countriesThymoglobulin induction in heart transplantation: patient selection and implications for maintenance immunosuppression.Recent advances in renal transplantation: antibody-mediated rejection takes center stageUtility of HLA Antibody Testing in Kidney Transplantation.Complement-Binding Donor-Specific Anti-HLA Antibodies and Risk of Primary Graft Failure in Hematopoietic Stem Cell TransplantationCapillary C4d and Kidney Allograft Outcome in Relation to Morphologic Lesions Suggestive of Antibody-Mediated RejectionInterpreting Anti-HLA Antibody Testing Data: A Practical Guide for Physicians
P2860
Q26738469-0FCDD16A-CD7D-4482-8636-A4489C1A9F11Q26749457-1D7A82F1-ECF0-4391-AB84-99B0F3365B20Q26774993-EFB7ECB1-0D34-4E5B-8BCC-71023C4F627CQ26823090-63CF2F7F-D53A-4B4F-9DB3-98011214DF05Q26825480-E52CD85F-70B9-4FCE-8EF2-0A2AAAF2B2C8Q26829296-5FCA70FA-C909-4A02-9FAA-910462C2729CQ26829790-1A9674D5-AA23-4F79-B49F-011D4B18DFE3Q26862195-AF19B25C-6FBA-4FF0-A4B9-A275A7861D68Q26995453-D3CBC7A8-83E8-48C8-90DF-80A9F5FACD9DQ27015921-4415D5CB-5B18-4B60-9E7C-C828E47F534EQ27024077-D6D3FE90-60F6-4A41-8C5E-FC08EBAE561EQ28069336-3A14FDF9-0F2D-4570-A130-375B829A7783Q28076012-A0C65D2C-D410-4947-AF23-F2D4D07D4633Q28076193-50336610-D0B7-40FE-9D23-BFD321508611Q28078919-3B9A1AA1-D26D-45F7-B264-5C03B8D7FEF2Q28084366-F054BBB5-1677-428E-AE8E-F96AE543FE22Q28087773-D07232C0-8363-40B3-99E7-6F59C6BBB7AEQ28109680-9E4643D9-F7A1-4A7C-AB0E-5AF8AD4F2517Q28554254-A343954C-B6B1-4FFC-B320-1CD8BD244BF9Q30397251-A0B99272-E6BE-4C6B-8721-99D6FD3FFE1FQ30397952-3A6D88AB-3177-4835-BB37-689C23204F24Q30491939-66269258-C678-4508-8018-6527ED58A72CQ33419651-B836BA9F-1171-40C0-AD44-C52B6E07BB71Q33658311-BEA6A678-AE74-483D-A1FA-6B3ADF0D499DQ33760357-06F5844E-18A5-442D-B156-59B176F5540CQ33814904-631BD811-88CD-462A-B0E3-9D5AA5C145B8Q33852943-DCDCDA82-B942-479C-82C0-E6836B9A17FAQ33874032-9BCFF426-C909-486C-918C-6B717AC6888FQ33877558-71F8CBC4-6D46-4288-A1B7-FB988A58F36CQ34047345-57F03D0E-675F-488A-9E69-AA2066767659Q34489123-B353F56B-96F0-4174-B980-881B02E3D92DQ35007419-F26881F8-1EC8-480A-AF46-6B8AAB75A4E1Q35027253-2CF00FA9-B555-4527-AC19-88541FB1B818Q35089829-EF3173F5-4EB9-400A-9485-4C50DA78DA93Q35175413-5C4725D8-E047-4750-930A-F1179668E197Q35659332-8A0706D5-AB98-414C-98C4-16F0ABD988FFQ35790601-9817415C-7468-4B99-9F69-C6BE7B67CE07Q35864018-4AAC3D92-225B-47D5-9F7E-22160F8E1647Q35922715-B88904F8-ECC7-42ED-B231-AF12E8B723A5Q36007256-710B47FC-A76A-4DFA-BA13-5D14B22A1ABD
P2860
Complement-binding anti-HLA antibodies and kidney-allograft survival.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Complement-binding anti-HLA antibodies and kidney-allograft survival.
@en
Complement-binding anti-HLA antibodies and kidney-allograft survival.
@nl
type
label
Complement-binding anti-HLA antibodies and kidney-allograft survival.
@en
Complement-binding anti-HLA antibodies and kidney-allograft survival.
@nl
prefLabel
Complement-binding anti-HLA antibodies and kidney-allograft survival.
@en
Complement-binding anti-HLA antibodies and kidney-allograft survival.
@nl
P2093
P356
P1476
Complement-binding anti-HLA antibodies and kidney-allograft survival.
@en
P2093
Alexandre Loupy
Arnaud Méjean
Carmen Lefaucheur
Caroline Suberbielle
Christof Prugger
Christophe Legendre
Dany Anglicheau
Denis Glotz
Dewi Vernerey
Dominique Charron
P304
P356
10.1056/NEJMOA1302506
P407
P577
2013-09-01T00:00:00Z